• Featured Product
  • KD/KO Validated

LIV-1/ZIP6 Polyclonal antibody

LIV-1/ZIP6 Polyclonal Antibody for IHC, WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat and More (1)

Applications

WB, IHC, IF, ELISA

Conjugate

Unconjugated

Cat no : 14236-1-AP

Synonyms

Ermelin, LIV 1, LIV1, LIV-1/ZIP6, SLC39A6, Zinc transporter ZIP6, ZIP 6, ZIP6, Zrt and Irt like protein 6



Tested Applications

Positive WB detected inHeLa cells, MCF-7 cells, A549 cells, 4T1 cells
Positive IHC detected inhuman pancreas cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:50-1:500
Sample-dependent, check data in validation data gallery

Product Information

14236-1-AP targets LIV-1/ZIP6 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, zebrafish
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen LIV-1/ZIP6 fusion protein Ag5478 相同性解析による交差性が予測される生物種
Full Name solute carrier family 39 (zinc transporter), member 6
Calculated molecular weight 85 kDa
Observed molecular weight 85-100 kDa, 48 and 32 kDa
GenBank accession numberBC039498
Gene symbol SLC39A6
Gene ID (NCBI) 25800
RRIDAB_10596924
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

The zinc transporter LIV-1 (also known as SLC39A6 or ZIP6) was originally identified as an estrogen-induced gene in breast cancer cells. Elevated LIV-1 expression is reportedly related to cancer progression in various types of cancer, including breast, prostate, pancreatic, cervical and liver cancers. While correlation of LIV-1 and prognosis may vary. LIV 1 has 3 isoforms with MW of 85-100 (glycosylation and phosphorylation), 48 and 32 kDa while migrates as different bands in different lysates in SDS-PAGE.

Protocols

Product Specific Protocols
WB protocol for LIV-1/ZIP6 antibody 14236-1-APDownload protocol
IHC protocol for LIV-1/ZIP6 antibody 14236-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB,IHC

Nat Genet

Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma.

Authors - Wu Chen C
  • KD Validated
humanWB

Gastroenterology

Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.

Authors - Xinxin Cheng
  • KD Validated
humanWB

Oncotarget

miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.

Authors - Junwei Lian
humanWB,IF

Oncotarget

Co-expression analysis revealed PTCH1-3'UTR promoted cell migration and invasion by activating miR-101-3p/SLC39A6 axis in non-small cell lung cancer: implicating the novel function of PTCH1.

Authors - Xuechao Wan
  • KD Validated
humanWB, IHC

J Transl Med

SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.

Authors - Xiao-Bin Cui
humanWB,IHC

Oncol Lett

Role of SLC39A6 in the development and progression of liver cancer.

Authors - Zhen Wan
  • KD Validated